Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma
Purpose To compare the diagnostic accuracy of contrast‐enhanced (CE) magnetic resonance imaging (MRI) and diffusion‐weighted MRI (DWI) in the differentiation between uterine leiomyosarcoma (LMS) / smooth muscle tumor with uncertain malignant potential (STUMP) and benign leiomyoma. Materials and Meth...
Saved in:
Published in | Journal of magnetic resonance imaging Vol. 43; no. 2; pp. 333 - 342 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.02.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1053-1807 1522-2586 |
DOI | 10.1002/jmri.24998 |
Cover
Loading…
Abstract | Purpose
To compare the diagnostic accuracy of contrast‐enhanced (CE) magnetic resonance imaging (MRI) and diffusion‐weighted MRI (DWI) in the differentiation between uterine leiomyosarcoma (LMS) / smooth muscle tumor with uncertain malignant potential (STUMP) and benign leiomyoma.
Materials and Methods
A consecutive cohort of 8 LMS/STUMP and 25 benign leiomyomas underwent pelvic MRI exam at 3T. Two radiologists independently evaluated images based on CE‐MRI (central nonenhancement at equilibrial phase) and DWI (hyperintensity on b = 1000 s/mm2 and hypointensity on apparent diffusion coefficients [ADC] map). The ADC values were calculated from b = 0 and 1000 s/mm2.
Results
CE‐MRI yielded a significantly superior diagnostic accuracy (0.94 vs. 0.52) and a significantly higher specificity (0.96 vs. 0.36) than DWI (P < 0.05 for both), and remained a comparably high sensitivity as DWI (0.88 vs. 1.00). A combination of DWI and ADC value <1.08 × 10−3 mm2/s (determined by receiver operating characteristic analysis) improved diagnostic accuracy, sensitivity, and specificity of DWI to 0.88, 0.88, and 0.88, respectively, by post‐hoc analysis based on the same study cohort.
Conclusion
For prospective differentiation between uterine LMS/STUMP and benign leiomyoma, CE‐MRI can provide accurate information and is preferable to DWI. Combination of DWI and ADC values can achieve a comparable diagnostic accuracy to CE‐MRI. J. Magn. Reson. Imaging 2016;43:333–342. |
---|---|
AbstractList | Purpose To compare the diagnostic accuracy of contrast-enhanced (CE) magnetic resonance imaging (MRI) and diffusion-weighted MRI (DWI) in the differentiation between uterine leiomyosarcoma (LMS) / smooth muscle tumor with uncertain malignant potential (STUMP) and benign leiomyoma. Materials and Methods A consecutive cohort of 8 LMS/STUMP and 25 benign leiomyomas underwent pelvic MRI exam at 3T. Two radiologists independently evaluated images based on CE-MRI (central nonenhancement at equilibrial phase) and DWI (hyperintensity on b = 1000 s/mm2 and hypointensity on apparent diffusion coefficients [ADC] map). The ADC values were calculated from b = 0 and 1000 s/mm2. Results CE-MRI yielded a significantly superior diagnostic accuracy (0.94 vs. 0.52) and a significantly higher specificity (0.96 vs. 0.36) than DWI (P < 0.05 for both), and remained a comparably high sensitivity as DWI (0.88 vs. 1.00). A combination of DWI and ADC value <1.08 × 10-3 mm2/s (determined by receiver operating characteristic analysis) improved diagnostic accuracy, sensitivity, and specificity of DWI to 0.88, 0.88, and 0.88, respectively, by post-hoc analysis based on the same study cohort. Conclusion For prospective differentiation between uterine LMS/STUMP and benign leiomyoma, CE-MRI can provide accurate information and is preferable to DWI. Combination of DWI and ADC values can achieve a comparable diagnostic accuracy to CE-MRI. J. Magn. Reson. Imaging 2016;43:333-342. PURPOSETo compare the diagnostic accuracy of contrast-enhanced (CE) magnetic resonance imaging (MRI) and diffusion-weighted MRI (DWI) in the differentiation between uterine leiomyosarcoma (LMS) / smooth muscle tumor with uncertain malignant potential (STUMP) and benign leiomyoma.MATERIALS AND METHODSA consecutive cohort of 8 LMS/STUMP and 25 benign leiomyomas underwent pelvic MRI exam at 3T. Two radiologists independently evaluated images based on CE-MRI (central nonenhancement at equilibrial phase) and DWI (hyperintensity on b = 1000 s/mm2 and hypointensity on apparent diffusion coefficients [ADC] map). The ADC values were calculated from b = 0 and 1000 s/mm2 .RESULTSCE-MRI yielded a significantly superior diagnostic accuracy (0.94 vs. 0.52) and a significantly higher specificity (0.96 vs. 0.36) than DWI (P < 0.05 for both), and remained a comparably high sensitivity as DWI (0.88 vs. 1.00). A combination of DWI and ADC value <1.08 × 10(-3) mm2 /s (determined by receiver operating characteristic analysis) improved diagnostic accuracy, sensitivity, and specificity of DWI to 0.88, 0.88, and 0.88, respectively, by post-hoc analysis based on the same study cohort.CONCLUSIONFor prospective differentiation between uterine LMS/STUMP and benign leiomyoma, CE-MRI can provide accurate information and is preferable to DWI. Combination of DWI and ADC values can achieve a comparable diagnostic accuracy to CE-MRI. Purpose To compare the diagnostic accuracy of contrast‐enhanced (CE) magnetic resonance imaging (MRI) and diffusion‐weighted MRI (DWI) in the differentiation between uterine leiomyosarcoma (LMS) / smooth muscle tumor with uncertain malignant potential (STUMP) and benign leiomyoma. Materials and Methods A consecutive cohort of 8 LMS/STUMP and 25 benign leiomyomas underwent pelvic MRI exam at 3T. Two radiologists independently evaluated images based on CE‐MRI (central nonenhancement at equilibrial phase) and DWI (hyperintensity on b = 1000 s/mm2 and hypointensity on apparent diffusion coefficients [ADC] map). The ADC values were calculated from b = 0 and 1000 s/mm2. Results CE‐MRI yielded a significantly superior diagnostic accuracy (0.94 vs. 0.52) and a significantly higher specificity (0.96 vs. 0.36) than DWI (P < 0.05 for both), and remained a comparably high sensitivity as DWI (0.88 vs. 1.00). A combination of DWI and ADC value <1.08 × 10−3 mm2/s (determined by receiver operating characteristic analysis) improved diagnostic accuracy, sensitivity, and specificity of DWI to 0.88, 0.88, and 0.88, respectively, by post‐hoc analysis based on the same study cohort. Conclusion For prospective differentiation between uterine LMS/STUMP and benign leiomyoma, CE‐MRI can provide accurate information and is preferable to DWI. Combination of DWI and ADC values can achieve a comparable diagnostic accuracy to CE‐MRI. J. Magn. Reson. Imaging 2016;43:333–342. To compare the diagnostic accuracy of contrast-enhanced (CE) magnetic resonance imaging (MRI) and diffusion-weighted MRI (DWI) in the differentiation between uterine leiomyosarcoma (LMS) / smooth muscle tumor with uncertain malignant potential (STUMP) and benign leiomyoma. A consecutive cohort of 8 LMS/STUMP and 25 benign leiomyomas underwent pelvic MRI exam at 3T. Two radiologists independently evaluated images based on CE-MRI (central nonenhancement at equilibrial phase) and DWI (hyperintensity on b = 1000 s/mm2 and hypointensity on apparent diffusion coefficients [ADC] map). The ADC values were calculated from b = 0 and 1000 s/mm2 . CE-MRI yielded a significantly superior diagnostic accuracy (0.94 vs. 0.52) and a significantly higher specificity (0.96 vs. 0.36) than DWI (P < 0.05 for both), and remained a comparably high sensitivity as DWI (0.88 vs. 1.00). A combination of DWI and ADC value <1.08 × 10(-3) mm2 /s (determined by receiver operating characteristic analysis) improved diagnostic accuracy, sensitivity, and specificity of DWI to 0.88, 0.88, and 0.88, respectively, by post-hoc analysis based on the same study cohort. For prospective differentiation between uterine LMS/STUMP and benign leiomyoma, CE-MRI can provide accurate information and is preferable to DWI. Combination of DWI and ADC values can achieve a comparable diagnostic accuracy to CE-MRI. |
Author | Huang, Yu-Ting Lin, Gigin Ng, Shu-Hang Yen, Tzu-Chen Yang, Lan-Yan Chang, Ting-Chang Lai, Chyong-Huey Chao, Angel Ng, Koon-Kwan Ueng, Shir-Hwa |
Author_xml | – sequence: 1 givenname: Gigin surname: Lin fullname: Lin, Gigin organization: Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital and Institute for Radiological Research, Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 2 givenname: Lan-Yan surname: Yang fullname: Yang, Lan-Yan organization: Clinical Trial Center, Chang Gung Memorial Hospital and Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 3 givenname: Yu-Ting surname: Huang fullname: Huang, Yu-Ting organization: Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital and Institute for Radiological Research, Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 4 givenname: Koon-Kwan surname: Ng fullname: Ng, Koon-Kwan organization: Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital and Institute for Radiological Research, Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 5 givenname: Shu-Hang surname: Ng fullname: Ng, Shu-Hang organization: Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital and Institute for Radiological Research, Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 6 givenname: Shir-Hwa surname: Ueng fullname: Ueng, Shir-Hwa organization: Department of Pathology, Chang Gung Memorial Hospital and Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 7 givenname: Angel surname: Chao fullname: Chao, Angel organization: Department of Obstetrics and Gynecology, Gynecology Oncology Research Center, Chang Gung Memorial Hospital and Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 8 givenname: Tzu-Chen surname: Yen fullname: Yen, Tzu-Chen organization: Department of Nuclear Medicine and Center for Advanced Molecular Imaging and Translation, Chang Gung Memorial Hospital and Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 9 givenname: Ting-Chang surname: Chang fullname: Chang, Ting-Chang email: tinchang.chang@gmail.com organization: Department of Obstetrics and Gynecology, Gynecology Oncology Research Center, Chang Gung Memorial Hospital and Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan – sequence: 10 givenname: Chyong-Huey surname: Lai fullname: Lai, Chyong-Huey organization: Department of Obstetrics and Gynecology, Gynecology Oncology Research Center, Chang Gung Memorial Hospital and Chang Gung University, Linkou Medical Center, Taoyuan, Guishan, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26383110$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kt1u1DAQhSNURH_ghgdAlrhBSGntZBPHl7BAabUFgUBcWhNnsuslthfb0bIPy7vg_etFhbiyNfOdMyOdOc9OrLOYZc8ZvWSUFldL4_VlMRGieZSdsaoo8qJq6pP0p1WZs4by0-w8hCWlVIhJ9SQ7LeqyKRmjZ9mfqTMr8Do4S1xP4gJJp2FuXYhaEVBq9KA225ZyNnoIMUe7AKuwI3dfbwjYLgn6fgza2XyNer6Ih5a2B7u-R482aoiJIS3GNaIlY0SvLZIBtTMbF8ArZ4BckWCciwtixqAGJHE0zpO1TpUxTfURkq-BQc8t2EhWLu6sh90mLdpUP1oaeJo97mEI-OzwXmTfP7z_Nv2Yzz5f30zfzHJVUdbkHZQt1B0yVtcciq5XnHdClKj6um2AY18VpWLIJgisROgY41wINkk9XlEsL7JXe9-Vd79GDFEaHRQOA1h0Y5CM17ThKQ2R0JcP0KUbvU3bJariomK03lIvDtTYGuzkymsDfiOPwSXg9R5Q3oXgsb9HGJXbq5Dbq5C7q0gwfQArHXdppET18G8J20vWesDNf8zlbcr6qMn3Gh0i_r7XgP8pa17ySv74dC1n4h19O2VfJCv_AvSd3t0 |
CitedBy_id | crossref_primary_10_1007_s00261_024_04704_y crossref_primary_10_1016_j_ejogrb_2020_05_040 crossref_primary_10_2147_IJWH_S388278 crossref_primary_10_1097_AOG_0000000000002334 crossref_primary_10_1080_02656736_2024_2418426 crossref_primary_10_3390_diagnostics13071223 crossref_primary_10_1007_s11547_023_01654_1 crossref_primary_10_1097_MD_0000000000019166 crossref_primary_10_3348_kjr_2023_0760 crossref_primary_10_1016_j_tjog_2016_04_033 crossref_primary_10_1186_s40644_019_0206_8 crossref_primary_10_3389_fonc_2024_1343533 crossref_primary_10_1259_bjr_20210283 crossref_primary_10_3390_healthcare7040158 crossref_primary_10_1016_j_fertnstert_2023_02_038 crossref_primary_10_1111_jog_13694 crossref_primary_10_1007_s11604_021_01096_7 crossref_primary_10_1007_s00261_022_03431_6 crossref_primary_10_1007_s00261_021_03263_w crossref_primary_10_1259_bjr_20200483 crossref_primary_10_2214_AJR_17_18605 crossref_primary_10_1017_S0266462318000168 crossref_primary_10_1007_s11604_021_01217_2 crossref_primary_10_1259_bjr_20201332 crossref_primary_10_3390_jcm14010088 crossref_primary_10_1007_s00261_021_03126_4 crossref_primary_10_1186_s12885_021_08113_y crossref_primary_10_1016_j_crad_2022_08_144 crossref_primary_10_1097_MD_0000000000034452 crossref_primary_10_3390_diagnostics14131438 crossref_primary_10_23736_S2724_606X_22_05126_0 crossref_primary_10_1016_j_gore_2023_101306 crossref_primary_10_3390_surgeries4030041 crossref_primary_10_3802_jgo_2024_35_e24 crossref_primary_10_1016_j_ijscr_2024_109556 crossref_primary_10_1148_radiol_2020191658 crossref_primary_10_5180_jsgoe_37_1_135 crossref_primary_10_5334_jbsr_2275 crossref_primary_10_1007_s00261_020_02734_w crossref_primary_10_1016_S1283_081X_19_42006_7 crossref_primary_10_1016_j_ejrad_2023_111217 crossref_primary_10_1097_RUQ_0000000000000454 crossref_primary_10_1007_s40944_024_00855_4 crossref_primary_10_1016_j_jogoh_2018_05_015 crossref_primary_10_3390_cancers14143517 crossref_primary_10_1007_s00330_020_07678_9 crossref_primary_10_1007_s00261_017_1076_9 crossref_primary_10_1016_j_crwh_2022_e00386 crossref_primary_10_1002_jmri_25981 crossref_primary_10_1155_2018_7890241 crossref_primary_10_2214_AJR_24_31280 crossref_primary_10_1016_j_rcl_2023_02_008 crossref_primary_10_3390_medicina59081371 crossref_primary_10_1148_rg_220161 crossref_primary_10_1007_s00261_022_03545_x crossref_primary_10_1016_j_ygyno_2019_07_002 crossref_primary_10_1155_2021_8880080 crossref_primary_10_1111_1471_0528_14579 crossref_primary_10_12677_acm_2024_1482398 crossref_primary_10_1016_j_acra_2018_11_014 crossref_primary_10_1016_j_jacr_2020_09_008 crossref_primary_10_1016_j_tjog_2022_08_003 crossref_primary_10_11648_j_ijcocr_20240904_11 crossref_primary_10_1016_j_ygyno_2017_02_019 crossref_primary_10_1007_s12149_017_1208_x crossref_primary_10_1016_j_ejro_2021_100328 crossref_primary_10_3389_fmed_2022_1069654 crossref_primary_10_1016_j_crad_2020_11_115 crossref_primary_10_1186_s40644_019_0247_z crossref_primary_10_1007_s00261_021_03132_6 crossref_primary_10_3892_mco_2019_1797 crossref_primary_10_1007_s00261_016_0924_3 crossref_primary_10_3348_kjr_2018_0090 crossref_primary_10_3390_diagnostics13081404 crossref_primary_10_1016_j_crad_2018_10_010 crossref_primary_10_3348_jksr_2021_0116 crossref_primary_10_1016_j_ejrad_2020_109406 crossref_primary_10_3390_jcm13216443 crossref_primary_10_1148_radiol_211658 crossref_primary_10_1097_RCT_0000000000000565 crossref_primary_10_1259_bjr_20210115 crossref_primary_10_3390_cancers14184468 crossref_primary_10_1097_RCT_0000000000001656 crossref_primary_10_3390_diagnostics10100735 crossref_primary_10_1016_j_clon_2017_05_005 crossref_primary_10_1097_MD_0000000000019787 crossref_primary_10_1016_j_jacr_2022_09_019 crossref_primary_10_1007_s40944_025_00967_5 crossref_primary_10_5387_fms_23_00018 crossref_primary_10_1007_s00438_024_02184_9 crossref_primary_10_1016_j_diii_2019_07_007 crossref_primary_10_1089_gyn_2019_0037 crossref_primary_10_1136_ijgc_2023_005220 crossref_primary_10_1016_j_cpet_2017_11_002 crossref_primary_10_25259_JCIS_24_2021 crossref_primary_10_1159_000494299 crossref_primary_10_1002_jmri_26630 crossref_primary_10_1007_s00261_024_04198_8 crossref_primary_10_1097_MNM_0000000000000612 crossref_primary_10_1097_CCO_0000000000000758 crossref_primary_10_1016_j_ejso_2023_107319 crossref_primary_10_1016_j_acra_2018_01_002 |
Cites_doi | 10.1016/j.ygyno.2009.02.020 10.1007/s00330-009-1471-x 10.1097/00000478-199406000-00001 10.1148/rg.236035033 10.1148/radiol.11102340 10.1148/radiology.189.3.8234695 10.1016/0002-9378(90)91298-Q 10.1148/radiol.2503080874 10.1148/radiology.158.2.3753623 10.1046/j.1525-1438.2002.01086.x 10.1002/jmri.20207 10.1055/s-0030-1251477 10.1016/j.ajog.2013.12.028 10.1148/radiographics.19.suppl_1.g99oc04s131 10.1016/j.ejrad.2009.03.005 10.1007/s00330-013-2819-9 10.2214/ajr.177.6.1771307 10.1016/j.ygyno.2003.12.029 10.1016/j.acra.2011.03.008 10.2214/ajr.181.5.1811369 10.1007/s00330-007-0787-7 10.1007/s00261-012-9919-x 10.1016/S1470-2045(09)70226-8 10.2214/AJR.11.7287 10.1016/j.bpobgyn.2011.07.002 |
ContentType | Journal Article |
Copyright | 2015 Wiley Periodicals, Inc. 2016 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2015 Wiley Periodicals, Inc. – notice: 2016 Wiley Periodicals, Inc. |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7TK 8FD FR3 K9. P64 7X8 |
DOI | 10.1002/jmri.24998 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-2586 |
EndPage | 342 |
ExternalDocumentID | 3925188561 26383110 10_1002_jmri_24998 JMRI24998 ark_67375_WNG_L9D0BC1Q_1 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GrantInformation_xml | – fundername: Chang Gung Medical Foundation funderid: CMRPG‐370444 ; 290262 – fundername: National Science Council, Taiwan funderid: NSC100‐2325‐B‐182‐008 ; NSC 103‐2314‐B‐182A‐006 ; NMRPD1A0842. IRB 97‐2366B. |
GroupedDBID | --- -DZ .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HDBZQ HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V8K V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QO 7TK 8FD FR3 K9. P64 7X8 |
ID | FETCH-LOGICAL-c5018-da3ba6de11667a2dfc77d993ecf6b8a7ef523c1e14ea13ead117799148a7750e3 |
IEDL.DBID | DR2 |
ISSN | 1053-1807 |
IngestDate | Fri Jul 11 00:42:47 EDT 2025 Sun Jul 13 03:48:20 EDT 2025 Mon Jul 21 05:59:20 EDT 2025 Tue Jul 01 03:56:33 EDT 2025 Thu Apr 24 22:57:21 EDT 2025 Wed Jan 22 16:46:18 EST 2025 Wed Oct 30 09:55:20 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | diagnostic accuracy magnetic resonance imaging diffusion-weighted imaging uterine sarcoma contrast enhancement |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2015 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5018-da3ba6de11667a2dfc77d993ecf6b8a7ef523c1e14ea13ead117799148a7750e3 |
Notes | National Science Council, Taiwan - No. NSC100-2325-B-182-008; No. NSC 103-2314-B-182A-006; No. NMRPD1A0842. IRB 97-2366B. ArticleID:JMRI24998 Chang Gung Medical Foundation - No. CMRPG-370444; No. 290262 ark:/67375/WNG-L9D0BC1Q-1 istex:C64F46F9B033AEE89ABD839673C64CC8577E36A6 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmri.24998 |
PMID | 26383110 |
PQID | 1757951069 |
PQPubID | 1006400 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1760870539 proquest_journals_1757951069 pubmed_primary_26383110 crossref_primary_10_1002_jmri_24998 crossref_citationtrail_10_1002_jmri_24998 wiley_primary_10_1002_jmri_24998_JMRI24998 istex_primary_ark_67375_WNG_L9D0BC1Q_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2016 |
PublicationDateYYYYMMDD | 2016-02-01 |
PublicationDate_xml | – month: 02 year: 2016 text: February 2016 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Nashville |
PublicationSubtitle | JMRI |
PublicationTitle | Journal of magnetic resonance imaging |
PublicationTitleAlternate | J. Magn. Reson. Imaging |
PublicationYear | 2016 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons; 1981. Sahdev A, Sohaib SA, Jacobs I, Shepherd JH, Oram DH, Reznek RH. MR imaging of uterine sarcomas. AJR Am J Roentgenol 2001;177:1307-1311. Rha SE, Byun JY, Jung SE, et al. CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 2003;181:1369-1374. Cornfeld D, Israel G, Martel M, Weinreb J, Schwartz P, McCarthy S. MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol 2010;74:241-249. Hricak H, Tscholakoff D, Heinrichs L, et al. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology 1986;158:385-391. Wang Y, Alkasab TK, Narin O, et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology 2011;260:105-111. Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol 2009;10:1188-1198. Thomassin-Naggara I, Dechoux S, Bonneau C, et al. How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol 2013;23:2306-2314. Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2006:CD005073. Ueda H, Togashi K, Konishi I, et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 1999;19(Spec No):S131-145. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004;93:204-208. Kido A, Togashi K, Koyama T, Yamaoka T, Fujiwara T, Fujii S. Diffusely enlarged uterus: evaluation with MR imaging. Radiographics 2003;23:1423-1439. Goto A, Takeuchi S, Sugimura K, Maruo T. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 2002;12:354-361. Tirumani SH, Ojili V, Shanbhogue AK, Fasih N, Ryan JG, Reinhold C. Current concepts in the imaging of uterine sarcoma. Abdom Imaging 2013;38:397-411. Lin G, Ng KK, Chang CJ, et al. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging-initial experience. Radiology 2009;250:784-792. Namimoto T, Yamashita Y, Awai K, et al. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2009;19:2756-2764. Leibsohn S, d'Ablaing G, Mishell DR Jr, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 1990;162:968-974; discussion 974-966. Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging 2004;20:998-1007. Tamai K, Koyama T, Saga T, et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008;18:723-730. Sato K, Yuasa N, Fujita M, Fukushima Y. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol 2014;210:368 e361-368. Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med 2010;28:204-217. Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2012;11:CD003857. Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology 1993;189:721-725. Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynecol 2011;25:681-689. Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol 2009;113:324-326. Kim HS, Baik JH, Pham LD, Jacobs MA. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 2011;18:970-976. Shah SH, Jagannathan JP, Krajewski K, O'Regan KN, George S, Ramaiya NH. Uterine sarcomas: then and now. AJR Am J Roentgenol 2012;199:213-223. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994;18:535-558. 2004; 20 1986; 158 2013; 23 2008; 18 2002; 12 2009; 113 2006 2009; 250 2014; 210 2012; 11 2011; 18 1993; 189 1990; 162 2001; 177 2012; 199 2009; 10 2004; 93 2013; 38 1999; 19 2010; 28 2003; 181 1994; 18 1981 2011; 25 2009; 19 2011; 260 2010; 74 2003; 23 e_1_2_6_10_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_11_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_15_1 e_1_2_6_16_1 Fleiss JL (e_1_2_6_21_1) 1981 Metwally M (e_1_2_6_7_1) 2012; 11 e_1_2_6_20_1 e_1_2_6_9_1 Gupta JK (e_1_2_6_8_1) 2006 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 Sato K (e_1_2_6_18_1) 2014; 210 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – reference: Goto A, Takeuchi S, Sugimura K, Maruo T. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 2002;12:354-361. – reference: Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol 2009;113:324-326. – reference: Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994;18:535-558. – reference: Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol 2009;10:1188-1198. – reference: Tirumani SH, Ojili V, Shanbhogue AK, Fasih N, Ryan JG, Reinhold C. Current concepts in the imaging of uterine sarcoma. Abdom Imaging 2013;38:397-411. – reference: Wang Y, Alkasab TK, Narin O, et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology 2011;260:105-111. – reference: Kim HS, Baik JH, Pham LD, Jacobs MA. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 2011;18:970-976. – reference: Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynecol 2011;25:681-689. – reference: Ueda H, Togashi K, Konishi I, et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 1999;19(Spec No):S131-145. – reference: Leibsohn S, d'Ablaing G, Mishell DR Jr, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 1990;162:968-974; discussion 974-966. – reference: Sahdev A, Sohaib SA, Jacobs I, Shepherd JH, Oram DH, Reznek RH. MR imaging of uterine sarcomas. AJR Am J Roentgenol 2001;177:1307-1311. – reference: Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology 1993;189:721-725. – reference: Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med 2010;28:204-217. – reference: Shah SH, Jagannathan JP, Krajewski K, O'Regan KN, George S, Ramaiya NH. Uterine sarcomas: then and now. AJR Am J Roentgenol 2012;199:213-223. – reference: Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004;93:204-208. – reference: Tamai K, Koyama T, Saga T, et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008;18:723-730. – reference: Hricak H, Tscholakoff D, Heinrichs L, et al. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology 1986;158:385-391. – reference: Thomassin-Naggara I, Dechoux S, Bonneau C, et al. How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol 2013;23:2306-2314. – reference: Rha SE, Byun JY, Jung SE, et al. CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 2003;181:1369-1374. – reference: Kido A, Togashi K, Koyama T, Yamaoka T, Fujiwara T, Fujii S. Diffusely enlarged uterus: evaluation with MR imaging. Radiographics 2003;23:1423-1439. – reference: Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2006:CD005073. – reference: Cornfeld D, Israel G, Martel M, Weinreb J, Schwartz P, McCarthy S. MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol 2010;74:241-249. – reference: Sato K, Yuasa N, Fujita M, Fukushima Y. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol 2014;210:368 e361-368. – reference: Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2012;11:CD003857. – reference: Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons; 1981. – reference: Namimoto T, Yamashita Y, Awai K, et al. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2009;19:2756-2764. – reference: Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging 2004;20:998-1007. – reference: Lin G, Ng KK, Chang CJ, et al. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging-initial experience. Radiology 2009;250:784-792. – start-page: CD005073 year: 2006 article-title: Uterine artery embolization for symptomatic uterine fibroids publication-title: Cochrane Database Syst Rev – volume: 74 start-page: 241 year: 2010 end-page: 249 article-title: MRI appearance of mesenchymal tumors of the uterus publication-title: Eur J Radiol – volume: 23 start-page: 1423 year: 2003 end-page: 1439 article-title: Diffusely enlarged uterus: evaluation with MR imaging publication-title: Radiographics – volume: 260 start-page: 105 year: 2011 end-page: 111 article-title: Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium‐based contrast agent guidelines publication-title: Radiology – year: 1981 – volume: 18 start-page: 723 year: 2008 end-page: 730 article-title: The utility of diffusion‐weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas publication-title: Eur Radiol – volume: 11 start-page: CD003857 year: 2012 article-title: Surgical treatment of fibroids for subfertility publication-title: Cochrane Database Syst Rev – volume: 18 start-page: 535 year: 1994 end-page: 558 article-title: Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases publication-title: Am J Surg Pathol – volume: 250 start-page: 784 year: 2009 end-page: 792 article-title: Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion‐weighted 3.0‐T MR imaging—initial experience publication-title: Radiology – volume: 18 start-page: 970 year: 2011 end-page: 976 article-title: MR‐guided high‐intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long‐term outcomes publication-title: Acad Radiol – volume: 19 start-page: 2756 year: 2009 end-page: 2764 article-title: Combined use of T2‐weighted and diffusion‐weighted 3‐T MR imaging for differentiating uterine sarcomas from benign leiomyomas publication-title: Eur Radiol – volume: 28 start-page: 204 year: 2010 end-page: 217 article-title: New directions in the epidemiology of uterine fibroids publication-title: Semin Reprod Med – volume: 113 start-page: 324 year: 2009 end-page: 326 article-title: Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis publication-title: Gynecol Oncol – volume: 12 start-page: 354 year: 2002 end-page: 361 article-title: Usefulness of Gd‐DTPA contrast‐enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus publication-title: Int J Gynecol Cancer – volume: 199 start-page: 213 year: 2012 end-page: 223 article-title: Uterine sarcomas: then and now publication-title: AJR Am J Roentgenol – volume: 20 start-page: 998 year: 2004 end-page: 1007 article-title: Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings publication-title: J Magn Reson Imaging – volume: 93 start-page: 204 year: 2004 end-page: 208 article-title: Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999 publication-title: Gynecol Oncol – volume: 23 start-page: 2306 year: 2013 end-page: 2314 article-title: How to differentiate benign from malignant myometrial tumours using MR imaging publication-title: Eur Radiol – volume: 19 start-page: S131 issue: Spec No year: 1999 end-page: 145 article-title: Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds publication-title: Radiographics – volume: 158 start-page: 385 year: 1986 end-page: 391 article-title: Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms publication-title: Radiology – volume: 38 start-page: 397 year: 2013 end-page: 411 article-title: Current concepts in the imaging of uterine sarcoma publication-title: Abdom Imaging – volume: 177 start-page: 1307 year: 2001 end-page: 1311 article-title: MR imaging of uterine sarcomas publication-title: AJR Am J Roentgenol – volume: 210 start-page: 368 year: 2014 article-title: Clinical application of diffusion‐weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma publication-title: Am J Obstet Gynecol – volume: 181 start-page: 1369 year: 2003 end-page: 1374 article-title: CT and MRI of uterine sarcomas and their mimickers publication-title: AJR Am J Roentgenol – volume: 162 start-page: 968 year: 1990 end-page: 974 article-title: Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas publication-title: Am J Obstet Gynecol – volume: 10 start-page: 1188 year: 2009 end-page: 1198 article-title: Clinical management of uterine sarcomas publication-title: Lancet Oncol – volume: 25 start-page: 681 year: 2011 end-page: 689 article-title: Clinical presentation and diagnosis of uterine sarcoma, including imaging publication-title: Best Pract Res Clin Obstet Gynecol – volume: 189 start-page: 721 year: 1993 end-page: 725 article-title: Hyperintense uterine leiomyoma at T2‐weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications publication-title: Radiology – ident: e_1_2_6_5_1 doi: 10.1016/j.ygyno.2009.02.020 – ident: e_1_2_6_17_1 doi: 10.1007/s00330-009-1471-x – ident: e_1_2_6_20_1 doi: 10.1097/00000478-199406000-00001 – ident: e_1_2_6_22_1 doi: 10.1148/rg.236035033 – ident: e_1_2_6_29_1 doi: 10.1148/radiol.11102340 – ident: e_1_2_6_13_1 doi: 10.1148/radiology.189.3.8234695 – ident: e_1_2_6_6_1 doi: 10.1016/0002-9378(90)91298-Q – ident: e_1_2_6_19_1 doi: 10.1148/radiol.2503080874 – ident: e_1_2_6_23_1 doi: 10.1148/radiology.158.2.3753623 – ident: e_1_2_6_24_1 doi: 10.1046/j.1525-1438.2002.01086.x – ident: e_1_2_6_12_1 doi: 10.1002/jmri.20207 – volume: 11 start-page: CD003857 year: 2012 ident: e_1_2_6_7_1 article-title: Surgical treatment of fibroids for subfertility publication-title: Cochrane Database Syst Rev – ident: e_1_2_6_4_1 doi: 10.1055/s-0030-1251477 – volume: 210 start-page: 368 year: 2014 ident: e_1_2_6_18_1 article-title: Clinical application of diffusion‐weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2013.12.028 – ident: e_1_2_6_14_1 doi: 10.1148/radiographics.19.suppl_1.g99oc04s131 – ident: e_1_2_6_15_1 doi: 10.1016/j.ejrad.2009.03.005 – ident: e_1_2_6_25_1 doi: 10.1007/s00330-013-2819-9 – ident: e_1_2_6_11_1 doi: 10.2214/ajr.177.6.1771307 – ident: e_1_2_6_3_1 doi: 10.1016/j.ygyno.2003.12.029 – ident: e_1_2_6_9_1 doi: 10.1016/j.acra.2011.03.008 – start-page: CD005073 year: 2006 ident: e_1_2_6_8_1 article-title: Uterine artery embolization for symptomatic uterine fibroids publication-title: Cochrane Database Syst Rev – ident: e_1_2_6_27_1 doi: 10.2214/ajr.181.5.1811369 – ident: e_1_2_6_16_1 doi: 10.1007/s00330-007-0787-7 – ident: e_1_2_6_28_1 doi: 10.1007/s00261-012-9919-x – ident: e_1_2_6_2_1 doi: 10.1016/S1470-2045(09)70226-8 – ident: e_1_2_6_26_1 doi: 10.2214/AJR.11.7287 – ident: e_1_2_6_10_1 doi: 10.1016/j.bpobgyn.2011.07.002 – volume-title: Statistical methods for rates and proportions year: 1981 ident: e_1_2_6_21_1 |
SSID | ssj0009945 |
Score | 2.4932623 |
Snippet | Purpose
To compare the diagnostic accuracy of contrast‐enhanced (CE) magnetic resonance imaging (MRI) and diffusion‐weighted MRI (DWI) in the differentiation... To compare the diagnostic accuracy of contrast-enhanced (CE) magnetic resonance imaging (MRI) and diffusion-weighted MRI (DWI) in the differentiation between... Purpose To compare the diagnostic accuracy of contrast-enhanced (CE) magnetic resonance imaging (MRI) and diffusion-weighted MRI (DWI) in the differentiation... PURPOSETo compare the diagnostic accuracy of contrast-enhanced (CE) magnetic resonance imaging (MRI) and diffusion-weighted MRI (DWI) in the differentiation... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 333 |
SubjectTerms | Adult contrast enhancement Contrast Media Diagnosis, Differential diagnostic accuracy Diffusion Magnetic Resonance Imaging diffusion-weighted imaging Female Humans Image Enhancement Image Interpretation, Computer-Assisted Leiomyoma - pathology Leiomyosarcoma - pathology Magnetic Resonance Imaging Middle Aged Prospective Studies Reproducibility of Results Sensitivity and Specificity Smooth Muscle Tumor - pathology Uterine Neoplasms - pathology uterine sarcoma |
Title | Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma |
URI | https://api.istex.fr/ark:/67375/WNG-L9D0BC1Q-1/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.24998 https://www.ncbi.nlm.nih.gov/pubmed/26383110 https://www.proquest.com/docview/1757951069 https://www.proquest.com/docview/1760870539 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB5KBfHF-yVaZUQRFLKbyT3gi67WWtyCxWJfZDhzia7dJCUXtD75E_yL-ks8M8lmqRRB35bMyexJcs6Zb2a-OYeQhxCKQKW5clXqB26o0aUEeMrFsKBy4ekI7EHa-V68cxDuHkaHG-Tp6ixMnx9iXHAznmHjtXFwEM10nTT0c1EvJjh5yMxJX0PWMohof507KstshWLED4HLUi8Zc5P60_Wtp0ajc-bFfj0Lap5Grnbo2b5EPqyU7hknR5OuFRP57Y98jv_7VJfJxQGT0me9EV0hG7q8Ss7Ph133a-TnbCxWSKucImSkqmfo4Q0UpOxqkCemyRLfoWl_ff-hy0-WXEDn-68plIqaUiydWZvDxi92QXZoXJRDl32plrY3FjowyKipOYFq0KVeVMVJ1aBnVgXQKW2KCs2MFl2DWtO2K6qammVlikN1T3SgBc4yPhqqDz2uWtv10uoidInXV10WcJ0cbL98N9txh9IQrjQZCF0FgYBYacbiOAFf5TJJFEItLfNYpJDoHCfYkmkWamABeovZm0YoHGIbYiQd3CCbZVXqW4QyBlGiItC5UGGexhmAAC2UZCLHcAcOebwyES6HvOmmfMeS9xmffW6-GbffzCEPRtnjPlvImVKPrKWNIlAfGX5dEvH3e6_4m-yF93zG3nLmkK2VKfIhtDQc8V5iYHGcOeT-2IxBwez0QKmrzsjEHgbiKECZm70Jj3_mY8QNEPQ55Ik1xL8oynfRCuyv2_8ifIdcQFg5cNu3yGZbd_ouQrdW3LMu-hvqoEmC |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF1BKwEv3C-BAotASCA5ieP7I6SUtCSRqFrRt9Wsdw2hsV35IihPfAK_CF_CzNpxVFQhwVuUGW_W8czs2dnxHMaegSsdFSbKUuHIsVyNLiVhqCwMCyqRQ-2BeZF2Nvcnh-7ekXfU1ubQuzBNf4gu4UaeYeI1OTglpAfrrqGf02LRx91DFF5km0TpTQQG2_vr7lFRZDiKEUE4lh0Og6476WiwvvbMerRJf-3X88DmWexqFp-daw3Daml6FlLNyXG_rmQ__vZHR8f_vq_r7GoLS_mrxo5usAs6u8kuzdqD91vs57jjK-R5whE1ctUU6eEFHOK4LiA-JZGpfYey-vX9h84-mfoCPtvf5ZApTmwsNaXnUPjF5GRb4SJrh2zYWqrGXnhbRMaJdgKnwZd6kaeneYnOmafAB7xMc7Q0ntYlzppXdZoXnDLLHFfrptaBp7jR-EjVPvwkr8zQSzMXqTP8fjVkCrfZ4c6bg_HEatkhrJiaEFoKHAm-0rbt-wGMVBIHgUK0pePElyEEOsE9dmxr29VgO-gwdDyNaNhFGcIk7dxhG1me6XuM2zZ4gfJAJ1K5SehHABK0VLEtE4x40GMvVjYi4rZ1OjF4LEXT9Hkk6JkJ88x67Gmne9I0DDlX67kxtU4FimMqsQs88WH-Vkyj7eHrsf1e2D22tbJF0UaXUiDkCwgZ-1GPPenEGBfosAcyndek4w8xFnsO6txtbLj7sREGXQdxX4-9NJb4l4mKPbQC8-n-vyg_ZpcnB7OpmO7O3z1gVxBltqXuW2yjKmr9EJFcJR8Zf_0NMRZNnA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2VVqp44X4JFFgEQgLJSdZ2fJF4gZTQliaCiqp9QatZ7xpCYzvyRVCe-AR-Eb6E2fUlKqqQ4C3KjDfj-Mzs2d3xDCGPwRWODGJpycB2LFehSwkYSgvDgozFUI3AvEg7nXk7h-7e8eh4jTxv34Wp60N0G27aM0y81g6-lPFgVTT0c5LP-7h4CIMLZMP10Fs0JTpYFY8KQ9OiGAmEY7Fg6HfFSe3B6toz09GG_me_nsc1z1JXM_dMLpMPrdV1yslJvypFP_r2R0HH_72tK-RSQ0rpixpFV8maSq-RzWlz7H6d_Bx33QppFlPkjFTWKXp4AYUoqnKITrXIZL5DUf76_kOln0x2AZ0e7FJIJdW9WCq9OYfCL2ZHthHO02bIuldLWaOFNilkVDedQDPoQs2z5DQr0DWzBOiAFkmGOKNJVaDVtKySLKd6X5niXF1nOtAElxkfda4PXWalGXphbBEqxe_bIRO4QQ4nr96Pd6ymN4QV6RKElgRHgCcVY57ngy3jyPclci0VxZ4IwFcxrrAjppirgDnoLvpwGrmwizIkScq5SdbTLFW3CWUMRr4cgYqFdOPACwEEKCEjJmKMd9AjT1uI8KgpnK77dyx4XfLZ5vqZcfPMeuRRp7usy4Wcq_XEIK1TgfxEJ9j5I340e833w-3hyzF7x1mPbLVQ5E1sKTgSPl_zYi_skYedGKOCPuqBVGWV1kGH8BH5qHOrhnD3YzaGXAdZX488M0D8i6F8D1FgPt35F-UHZPPt9oTv787e3CUXkWI2ee5bZL3MK3UPaVwp7htv_Q1JOExU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+the+diagnostic+accuracy+of+contrast-enhanced+MRI+and+diffusion-weighted+MRI+in+the+differentiation+between+uterine+leiomyosarcoma+%2F+smooth+muscle+tumor+with+uncertain+malignant+potential+and+benign+leiomyoma&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Lin%2C+Gigin&rft.au=Yang%2C+Lan-Yan&rft.au=Huang%2C+Yu-Ting&rft.au=Ng%2C+Koon-Kwan&rft.date=2016-02-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1053-1807&rft.eissn=1522-2586&rft.volume=43&rft.issue=2&rft.spage=333&rft_id=info:doi/10.1002%2Fjmri.24998&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3925188561 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon |